Atropine Dosing for Organophosphate Poisoning

Clinical Indicators for Atropine Administration

The American Society of Anesthesiologists recommends atropine administration in the presence of muscarinic symptoms, such as excessive secretions, bronchospasm, bradycardia, and miosis 1
The American College of Medical Toxicology suggests that hemodynamic compromise, including hypotension and altered mental status, is an indication for atropine administration, although this specific guideline is from Praxis Medical Insights, a similar recommendation can be found from other sources 2

The American Academy of Pediatrics recommends an initial atropine dose of 0.02-0.05 mg/kg IV for pediatric patients 3
The maximum single dose of atropine is typically 2-3 mg, as recommended by the American Society of Anesthesiologists 1

The American Society of Anesthesiologists recommends oximes, such as pralidoxime, at a dose of 1-2 g IV initially, followed by 500 mg/hr continuous infusion, as an adjunct to atropine therapy 1
The American Society of Anesthesiologists also suggests the use of benzodiazepines, such as midazolam or diazepam, for seizure control and anxiety in patients with organophosphate poisoning 1

The American College of Medical Toxicology recommends monitoring heart rate and blood pressure, with a target of normalizing vital signs, as an indicator of effective atropine therapy, although this specific guideline is from Praxis Medical Insights, a similar recommendation can be found from other sources 2
The American Society of Anesthesiologists suggests monitoring pupil size, with resolution of miosis as an indicator of effective atropine therapy 1